Chemed Corporation (FRA:CXM)
Germany · Delayed Price · Currency is EUR 372.00
-4.00 (-1.06%)
Last updated: Jan 26, 2026, 8:14 AM CET
Chemed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,531 | 2,431 | 2,264 | 2,135 | 2,139 | 2,080 | |
Revenue Growth (YoY) | 6.45% | 7.37% | 6.06% | -0.20% | 2.87% | 7.27% |
Cost of Revenue | 1,699 | 1,577 | 1,466 | 1,370 | 1,369 | 1,378 |
Gross Profit | 832.13 | 854.35 | 798.82 | 765.09 | 769.8 | 701.39 |
Selling, General & Admin | 415.9 | 419.02 | 395.12 | 358.73 | 366.73 | 330.22 |
Amortization of Goodwill & Intangibles | 10.28 | 10.19 | 10.06 | 10.07 | 10.04 | 9.99 |
Operating Expenses | 480.18 | 482.07 | 455.99 | 417.9 | 425.78 | 386.8 |
Operating Income | 351.95 | 372.28 | 342.83 | 347.19 | 344.03 | 314.59 |
Interest Expense | -1.73 | -1.78 | -3.11 | -4.58 | -1.87 | -2.36 |
Interest & Investment Income | 10.39 | 14.61 | 6.27 | 0.36 | 0.38 | 0.76 |
Other Non Operating Income (Expenses) | 10.32 | 20.14 | 6.64 | -9.59 | 8.77 | 7.91 |
EBT Excluding Unusual Items | 370.94 | 405.25 | 352.63 | 333.37 | 351.3 | 320.9 |
Gain (Loss) on Sale of Assets | -0.45 | -0.45 | -0.21 | 0.31 | -0.99 | -0.54 |
Legal Settlements | - | - | -2.05 | -4 | - | -4.59 |
Other Unusual Items | -0.04 | -5.34 | - | - | - | 80.23 |
Pretax Income | 370.46 | 399.47 | 350.37 | 329.68 | 350.31 | 395.99 |
Income Tax Expense | 91.65 | 97.47 | 77.86 | 80.06 | 81.76 | 76.52 |
Net Income | 278.81 | 302 | 272.51 | 249.62 | 268.55 | 319.47 |
Net Income to Common | 278.81 | 302 | 272.51 | 249.62 | 268.55 | 319.47 |
Net Income Growth | -7.60% | 10.82% | 9.17% | -7.05% | -15.94% | 45.26% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 16 | 16 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 16 | 16 |
Shares Change (YoY) | -3.57% | -0.09% | 0.67% | -5.26% | -2.80% | -0.78% |
EPS (Basic) | 19.08 | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 |
EPS (Diluted) | 18.95 | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 |
EPS Growth | -4.21% | 10.93% | 8.47% | -1.90% | -13.50% | 46.36% |
Free Cash Flow | 360.44 | 367.97 | 273.45 | 252.56 | 249.92 | 430.46 |
Free Cash Flow Per Share | 24.50 | 24.23 | 17.99 | 16.73 | 15.68 | 26.25 |
Dividend Per Share | 2.100 | 1.800 | 1.560 | 1.480 | 1.560 | 1.320 |
Dividend Growth | 23.53% | 15.38% | 5.41% | -5.13% | 18.18% | 6.45% |
Gross Margin | 32.88% | 35.14% | 35.28% | 35.84% | 35.98% | 33.73% |
Operating Margin | 13.91% | 15.31% | 15.14% | 16.26% | 16.08% | 15.13% |
Profit Margin | 11.02% | 12.42% | 12.03% | 11.69% | 12.55% | 15.36% |
Free Cash Flow Margin | 14.24% | 15.14% | 12.08% | 11.83% | 11.68% | 20.70% |
EBITDA | 412 | 431.03 | 399.2 | 400.86 | 397.28 | 365.67 |
EBITDA Margin | 16.28% | 17.73% | 17.63% | 18.78% | 18.57% | 17.58% |
D&A For EBITDA | 60.04 | 58.75 | 56.37 | 53.67 | 53.25 | 51.08 |
EBIT | 351.95 | 372.28 | 342.83 | 347.19 | 344.03 | 314.59 |
EBIT Margin | 13.91% | 15.31% | 15.14% | 16.26% | 16.08% | 15.13% |
Effective Tax Rate | 24.74% | 24.40% | 22.22% | 24.28% | 23.34% | 19.32% |
Advertising Expenses | - | 78.8 | 72.2 | 68.6 | 62.1 | 54.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.